Canada Markets open in 1 hr 44 mins

BeiGene, Ltd. (BGNE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
254.28-1.72 (-0.67%)
At close: 04:00PM EST
254.30 +0.02 (+0.01%)
Pre-Market: 07:10AM EST
Full screen
Trade prices are not sourced from all markets
Previous Close256.00
Bid0.00 x 800
Ask270.00 x 800
Day's Range248.60 - 260.00
52 Week Range118.18 - 280.62
Avg. Volume271,232
Market Cap27.014B
Beta (5Y Monthly)0.73
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Zacks

    Jazz (JAZZ) Gastric Cancer Study Shows Improved Overall Survival

    Jazz (JAZZ) reports data from a mid-stage study on its investigational bispecific antibody targeting HER2-expressing mGEA. The treatment achieved an overall survival rate of 84% in 18 months.

  • Zacks

    What Makes BeiGene, Ltd. (BGNE) a Good Fit for 'Trend Investing'

    If you are looking for stocks that are well positioned to maintain their recent uptrend, BeiGene, Ltd. (BGNE) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.

  • Motley Fool

    Why Shares of BeiGene Were Up Wednesday

    Shares of Chinese pharmaceutical BeiGene (NASDAQ: BGNE) rose as high as 12.8% in early trading on Wednesday. BeiGene didn't make any big announcements, and its earnings report was back on Nov. 9, so the move was curious. Most likely, it was just a little bit of a return to normalcy after the stock took a beating when there were protests in China regarding the country's strict lockdown "zero tolerance" provisions regarding COVID-19.